219 related articles for article (PubMed ID: 17560548)
41. Novel role of presenilins in maturation and transport of integrin beta 1.
Zou K; Hosono T; Nakamura T; Shiraishi H; Maeda T; Komano H; Yanagisawa K; Michikawa M
Biochemistry; 2008 Mar; 47(11):3370-8. PubMed ID: 18293935
[TBL] [Abstract][Full Text] [Related]
42. Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells.
Lindberg K; Ström A; Lock JG; Gustafsson JA; Haldosén LA; Helguero LA
J Cell Physiol; 2010 Jan; 222(1):156-67. PubMed ID: 19780039
[TBL] [Abstract][Full Text] [Related]
43. Dissecting the diverse functions of the metastasis suppressor CD82/KAI1.
Tsai YC; Weissman AM
FEBS Lett; 2011 Oct; 585(20):3166-73. PubMed ID: 21875585
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of the correlation of vasculogenic mimicry, Notch4, DLL4, and KAI1/CD82 in the prediction of metastasis and prognosis in non-small cell lung cancer.
Wang Y; Yang R; Wang X; Ci H; Zhou L; Zhu B; Wu S; Wang D
Medicine (Baltimore); 2018 Dec; 97(52):e13817. PubMed ID: 30593175
[TBL] [Abstract][Full Text] [Related]
45. KAI1/CD82 suppresses hepatocyte growth factor-induced migration of hepatoma cells via upregulation of Sprouty2.
Mu Z; Wang H; Zhang J; Li Q; Wang L; Guo X
Sci China C Life Sci; 2008 Jul; 51(7):648-54. PubMed ID: 18622748
[TBL] [Abstract][Full Text] [Related]
46. Detection of a hypersialylated beta1 integrin endogenously expressed in the human astrocytoma cell line A172.
Bartik P; Maglott A; Entlicher G; Vestweber D; Takeda K; Martin S; Dontenwill M
Int J Oncol; 2008 May; 32(5):1021-31. PubMed ID: 18425328
[TBL] [Abstract][Full Text] [Related]
47. Loss of KAI1/CD82 expression in bone and soft tissue tumors is not associated with lung metastasis.
Arihiro K; Inai K
Pathol Res Pract; 2001; 197(9):627-33. PubMed ID: 11569927
[TBL] [Abstract][Full Text] [Related]
48. Transduction of KAI1/CD82 cDNA promotes hematogenous spread of human lung-cancer cells in natural killer cell-depleted SCID mice.
Shinohara T; Nishimura N; Hanibuchi M; Nokihara H; Miki T; Hamada H; Sone S
Int J Cancer; 2001 Oct; 94(1):16-23. PubMed ID: 11668473
[TBL] [Abstract][Full Text] [Related]
49. Metabolomic Detection Between Pancreatic Cancer and Liver Metastasis Nude Mouse Models Constructed by Using the PANC1-KAI1/CD
Wang S; Chen J; Li H; Qi X; Liu X; Guo X
Technol Cancer Res Treat; 2021; 20():15330338211045204. PubMed ID: 34605330
[No Abstract] [Full Text] [Related]
50. Metastasis-suppressor KAI1/CD82 induces homotypic aggregation of human prostate cancer cells through Src-dependent pathway.
Jee B; Jin K; Hahn JH; Song HG; Lee H
Exp Mol Med; 2003 Feb; 35(1):30-7. PubMed ID: 12642901
[TBL] [Abstract][Full Text] [Related]
51. Integrin beta1-dependent invasive migration of irradiation-tolerant human lung adenocarcinoma cells in 3D collagen matrix.
Ishihara S; Haga H; Yasuda M; Mizutani T; Kawabata K; Shirato H; Nishioka T
Biochem Biophys Res Commun; 2010 Jun; 396(3):651-5. PubMed ID: 20438698
[TBL] [Abstract][Full Text] [Related]
52. The peptide mimicking small extracellular ring domain of CD82 inhibits tumor cell migration in vitro and metastasis in vivo.
He X; Ma X; Wang C; Luan M; Li Y; Huang X; Ma K
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1927-1934. PubMed ID: 33811273
[TBL] [Abstract][Full Text] [Related]
53. MGAT3-mediated glycosylation of tetraspanin CD82 at asparagine 157 suppresses ovarian cancer metastasis by inhibiting the integrin signaling pathway.
Li J; Xu J; Li L; Ianni A; Kumari P; Liu S; Sun P; Braun T; Tan X; Xiang R; Yue S
Theranostics; 2020; 10(14):6467-6482. PubMed ID: 32483464
[No Abstract] [Full Text] [Related]
54. Down-regulation of the expression of beta1,4-galactosyltransferase V promotes integrin beta1 maturation.
Chen X; Jiang J; Yang J; Chen C; Sun M; Wei Y; Guang X; Gu J
Biochem Biophys Res Commun; 2006 May; 343(3):910-6. PubMed ID: 16564504
[TBL] [Abstract][Full Text] [Related]
55. Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation.
Ono M; Handa K; Withers DA; Hakomori S
Cancer Res; 1999 May; 59(10):2335-9. PubMed ID: 10344740
[TBL] [Abstract][Full Text] [Related]
56. Expression of KAI1/CD82 in human colorectal tumor.
Wu DH; Liu L; Chen LH; Ding YQ
Di Yi Jun Yi Da Xue Xue Bao; 2003 Jul; 23(7):714-5, 719. PubMed ID: 12865229
[TBL] [Abstract][Full Text] [Related]
57. KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factor: an immunohistochemical analysis.
Higashiyama M; Kodama K; Yokouchi H; Takami K; Adachi M; Taki T; Ishiguro S; Nakamori S; Yoshie O; Miyake M
Cancer; 1998 Aug; 83(3):466-74. PubMed ID: 9690539
[TBL] [Abstract][Full Text] [Related]
58. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
59. Limited value of KAI1/CD82 protein expression as a prognostic marker in human gastric cancer.
Knoener M; Krech T; Puls F; Lehmann U; Kreipe H; Christgen M
Dis Markers; 2012; 32(6):337-42. PubMed ID: 22684230
[TBL] [Abstract][Full Text] [Related]
60. Overexpression of KAI1/CD82 suppresses in vitro cell growth, migration, invasion and xenograft growth in oral cancer.
Chai J; Du L; Ju J; Ma C; Shen Z; Yang X; Liang L; Ni Q; Sun M
Mol Med Rep; 2017 Apr; 15(4):1527-1532. PubMed ID: 28260006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
